RE
PASG icon

RBC Europe’s Passage Bio PASG Stock Holding History

RBC Europe’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7
Closed -$1.47K – 985
2021
Q3 		$1.47K Hold
7
– – ﹤0.01% 1157
2021
Q2 		$1.96K Hold
7
– – ﹤0.01% 1127
2021
Q1 		$2.59K Hold
7
– – ﹤0.01% 1057
2020
Q4 		$3.78K Hold
7
– – ﹤0.01% 1004
2020
Q3 		$1.94K Buy
+7
New +$2.41K ﹤0.01% 988

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RBC Europe's PASG Position: Q4 2021 in Review

RBC Europe sold out of Passage Bio (PASG) in Q4 2021, closing a stake of 7 shares — an estimated $1.47K sold.

RBC Europe first reported a position in PASG in Q3 2020 and held it in 5 quarters. The position peaked at $3.78K in Q4 2020. 99 funds tracked by Wall St. Rank hold PASG as of Q4 2021.

  • RBC Europe reported no remaining Passage Bio position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 7 Passage Bio shares in Q4 2021, an estimated $1.47K.
  • RBC Europe first reported a position in Passage Bio in Q3 2020 and held it in 5 quarters.
  • RBC Europe's Passage Bio position peaked at $3.78K in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Passage Bio as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.